Ursodiol Capsule
Product Images NDC 70710-1483

2 FDA label images from Zydus Pharmaceuticals (usa) Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ursodiol (NDC 70710-1483). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (10ca538c 58bf 440d 890e Be0354693812 01)

Image (10ca538c 58bf 440d 890e Be0354693812 01)
Chemical structure of ursodiol, depicting its steroid framework with hydroxyl (OH) groups and a carboxyl (COOH) side chain, consistent with its identification as the active ingredient ursodiol.*
FDA Label Image

Label (10ca538c 58bf 440d 890e Be0354693812 02)

Label (10ca538c 58bf 440d 890e Be0354693812 02)
Label for Ursodiol Capsules, USP 300 mg oral capsules by Zydus Pharmaceuticals (USA) Inc. The package contains 100 capsules. The label includes storage instructions, dosage note, child-resistant packaging warning, and manufacturer information (Cadila Healthcare Ltd., India). The NDC is 70710-1483-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.